Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by newdaydawningon Feb 10, 2019 10:13pm
73 Views
Post# 29344999

RE:RE:Is CelluForce an obvious partner for PGX?

RE:RE:Is CelluForce an obvious partner for PGX?You are right Ciao, there is no reference to PGX for NCC in CZO's investor presentation. Nonetheless, it was spelled out as a big opportunity in prior-year presentations.

The fact that CZO appears to have abandoned the opportunity was the point of my post. And frankly, that is probably why the stock continues to be a laggard.

Instead of capitalizing on the tremendous opportunity with NCC, Gagnon chose to take on his customers by paying too much for high-end cosmetics company that is doomed to failure.

Gagnon also dismissed the cannabis opportunity. And here we are - worth a fraction of what we could be  --- with decent managment.

Gagnon needs to be replaced. Pure and simple!



Ciao wrote: do you have a reference for this?

For years, we've heard Gagnon gush about the applicability of PGX to the processing of NCC.

this is a bit harsh, isn't it? The POTUS can't even be made to answer anything!

Gagnon should be made to answer.


Bullboard Posts